MyBio Ltd. announces a new exclusive partnership with QIAGEN, a leading global provider, to distribute their leading Life Science ?Sample to Insight? product range throughout Ireland and Northern Ireland with effect from April 1st, 2024. This exclusivity refers to Life Science products for the respective customer base and does not extend to other product portfolios of QIAGEN such as IVD regulated products, HID, Instrument Service or QDI products or customer segments.

Under this new agreement MyBio Ltd. will be responsible for marketing QIAGEN Life Science technologies for the molecular analysis of any type of biological sample; from sample collection, its disruption, the purification of DNA, RNA and proteins and its identification and quantification using the most advanced technologies on the market. This new partnership extends QIAGEN?S reach into the Irish life science market by leveraging MyBio Ltd.?s strong commercial presence and deep ties within the Academic, Biopharma and Agri-Bioscience industries in Ireland and Northern Ireland. Under the terms of the agreement, MyBio Ltd. will exclusively supply the QIAGEN Life Science research product range to the academic research, biopharma, and agri-bioscience industries across the Island of Ireland.